US830930A
(en)
|
1905-11-22 |
1906-09-11 |
E & T Fairbanks & Co |
Weighing-scale.
|
CH588505A5
(es)
|
1972-06-08 |
1977-06-15 |
Research Corp |
|
NL7802170A
(nl)
|
1977-04-18 |
1978-10-20 |
Hitachi Metals Ltd |
Sierraad.
|
US4526988A
(en)
|
1983-03-10 |
1985-07-02 |
Eli Lilly And Company |
Difluoro antivirals and intermediate therefor
|
US4737456A
(en)
|
1985-05-09 |
1988-04-12 |
Syntex (U.S.A.) Inc. |
Reducing interference in ligand-receptor binding assays
|
US4676980A
(en)
|
1985-09-23 |
1987-06-30 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Target specific cross-linked heteroantibodies
|
US5597531A
(en)
|
1985-10-04 |
1997-01-28 |
Immunivest Corporation |
Resuspendable coated magnetic particles and stable magnetic particle suspensions
|
US6548640B1
(en)
|
1986-03-27 |
2003-04-15 |
Btg International Limited |
Altered antibodies
|
FR2601675B1
(fr)
|
1986-07-17 |
1988-09-23 |
Rhone Poulenc Sante |
Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
|
IL85035A0
(en)
|
1987-01-08 |
1988-06-30 |
Int Genetic Eng |
Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
|
WO1990005144A1
(en)
|
1988-11-11 |
1990-05-17 |
Medical Research Council |
Single domain ligands, receptors comprising said ligands, methods for their production, and use of said ligands and receptors
|
DE3920358A1
(de)
|
1989-06-22 |
1991-01-17 |
Behringwerke Ag |
Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
|
US6020145A
(en)
|
1989-06-30 |
2000-02-01 |
Bristol-Myers Squibb Company |
Methods for determining the presence of carcinoma using the antigen binding region of monoclonal antibody BR96
|
US5698271A
(en)
|
1989-08-22 |
1997-12-16 |
Immunivest Corporation |
Methods for the manufacture of magnetically responsive particles
|
US5208020A
(en)
|
1989-10-25 |
1993-05-04 |
Immunogen Inc. |
Cytotoxic agents comprising maytansinoids and their therapeutic use
|
US5959177A
(en)
|
1989-10-27 |
1999-09-28 |
The Scripps Research Institute |
Transgenic plants expressing assembled secretory antibodies
|
US5859205A
(en)
|
1989-12-21 |
1999-01-12 |
Celltech Limited |
Humanised antibodies
|
US6075181A
(en)
|
1990-01-12 |
2000-06-13 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
US6150584A
(en)
|
1990-01-12 |
2000-11-21 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
US5770429A
(en)
|
1990-08-29 |
1998-06-23 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
ATE164395T1
(de)
|
1990-12-03 |
1998-04-15 |
Genentech Inc |
Verfahren zur anreicherung von proteinvarianten mit geänderten bindungseigenschaften
|
US5571894A
(en)
|
1991-02-05 |
1996-11-05 |
Ciba-Geigy Corporation |
Recombinant antibodies specific for a growth factor receptor
|
DK0590058T3
(da)
|
1991-06-14 |
2004-03-29 |
Genentech Inc |
Humaniseret heregulin-antistof
|
GB9114948D0
(en)
|
1991-07-11 |
1991-08-28 |
Pfizer Ltd |
Process for preparing sertraline intermediates
|
US5565332A
(en)
|
1991-09-23 |
1996-10-15 |
Medical Research Council |
Production of chimeric antibodies - a combinatorial approach
|
US5587458A
(en)
|
1991-10-07 |
1996-12-24 |
Aronex Pharmaceuticals, Inc. |
Anti-erbB-2 antibodies, combinations thereof, and therapeutic and diagnostic uses thereof
|
EP0625200B1
(en)
|
1992-02-06 |
2005-05-11 |
Chiron Corporation |
Biosynthetic binding protein for cancer marker
|
US5489525A
(en)
|
1992-10-08 |
1996-02-06 |
The United States Of America As Represented By The Department Of Health And Human Services |
Monoclonal antibodies to prostate cells
|
ATE196606T1
(de)
|
1992-11-13 |
2000-10-15 |
Idec Pharma Corp |
Therapeutische verwendung von chimerischen und markierten antikörpern, die gegen ein differenzierung-antigen gerichtet sind, dessen expression auf menschliche b lymphozyt beschränkt ist, für die behandlung von b-zell-lymphoma
|
CA2153480A1
(en)
|
1993-11-12 |
1995-06-01 |
Kenichi Matsubara |
Gene signature
|
US5731168A
(en)
|
1995-03-01 |
1998-03-24 |
Genentech, Inc. |
Method for making heteromultimeric polypeptides
|
US5869046A
(en)
|
1995-04-14 |
1999-02-09 |
Genentech, Inc. |
Altered polypeptides with increased half-life
|
GB9603256D0
(en)
|
1996-02-16 |
1996-04-17 |
Wellcome Found |
Antibodies
|
US5859045A
(en)
|
1996-05-08 |
1999-01-12 |
Novo Nordisk A/S Novo Alle |
Crystalline -! 3R 4R-trans-7 methoxy 2,2-dimethyl1-3-phenyl 1-4 4-12 pyrrolidin-1 -Y1!ethoxyl 1!chromane hydrogen fumarate
|
US5824504A
(en)
|
1996-09-26 |
1998-10-20 |
Elshourbagy; Nabil A. |
Human 7-transmembrane receptor and DNA
|
AU5243198A
(en)
|
1996-10-30 |
1998-05-22 |
Uab Research Foundation, The |
Enhancement of tumor cell chemosensitivity and radiosensitivity using single chain intracellular antibodies
|
AR012035A1
(es)
|
1997-02-25 |
2000-09-27 |
Corixa Corp |
Metodo para detectar el cancer de prostata, metodo para monitorear el desarrollo del cancer de prostata, anticuerpo monoclonal que se une a un polipeptido, una cantidad terapeutica eficaz de anticuerpos monoclonales para preparar medicamentos y equipo para diagnostico
|
TR199902053T2
(xx)
|
1997-02-25 |
2000-04-21 |
Corixa Corporation |
Prostat kanserinin immunoterapisine y�nelik bile�ikler ve bunlar�n kullan�lmas�na matuf metodlar.
|
US6800746B2
(en)
|
1997-02-25 |
2004-10-05 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
ES2246069T3
(es)
|
1997-05-02 |
2006-02-01 |
Genentech, Inc. |
Procedimiento de preparacion de anticuerpos multiespecificos que tienen componentes comunes y multimericos.
|
EP0983357A1
(en)
|
1997-05-23 |
2000-03-08 |
Biogen, Inc. |
Modulators of tissue regeneration
|
EP0994903B1
(en)
|
1997-06-24 |
2005-05-25 |
Genentech, Inc. |
Methods and compositions for galactosylated glycoproteins
|
JP2001512013A
(ja)
|
1997-08-01 |
2001-08-21 |
ジェンセット |
前立腺に発現される分泌タンパク質の5’est
|
ES2267192T3
(es)
|
1997-08-01 |
2007-03-01 |
Serono Genetics Institute S.A. |
Ests 5' para proteinas secretadas no especificas de tejido.
|
US6040498A
(en)
|
1998-08-11 |
2000-03-21 |
North Caroline State University |
Genetically engineered duckweed
|
JPH1164691A
(ja)
|
1997-08-25 |
1999-03-05 |
Furukawa Electric Co Ltd:The |
無切断クリップ
|
US20030060612A1
(en)
|
1997-10-28 |
2003-03-27 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
WO1999022764A1
(en)
|
1997-10-31 |
1999-05-14 |
Genentech, Inc. |
Methods and compositions comprising glycoprotein glycoforms
|
US6610833B1
(en)
|
1997-11-24 |
2003-08-26 |
The Institute For Human Genetics And Biochemistry |
Monoclonal human natural antibodies
|
PT1034298E
(pt)
|
1997-12-05 |
2012-02-03 |
Scripps Research Inst |
Humanização de anticorpo murino
|
EP1062515B1
(en)
|
1998-02-12 |
2009-11-25 |
Immunivest Corporation |
Methods and reagents for the rapid and efficient isolation of circulating cancer cells
|
WO1999054342A1
(en)
|
1998-04-20 |
1999-10-28 |
Pablo Umana |
Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity
|
US20030064397A1
(en)
|
1998-05-22 |
2003-04-03 |
Incyte Genomics, Inc. |
Transmembrane protein differentially expressed in prostate and lung tumors
|
US6048970A
(en)
|
1998-05-22 |
2000-04-11 |
Incyte Pharmaceuticals, Inc. |
Prostate growth-associated membrane proteins
|
US6833438B1
(en)
|
1999-06-01 |
2004-12-21 |
Agensys, Inc. |
Serpentine transmembrane antigens expressed in human cancers and uses thereof
|
ATE437947T1
(de)
|
1998-06-01 |
2009-08-15 |
Agensys Inc |
Serpentintransmembranantigene exprimiert in menschlichem krebs und deren verwendungen
|
US20030149531A1
(en)
|
2000-12-06 |
2003-08-07 |
Hubert Rene S. |
Serpentine transmembrane antigens expressed in human cancers and uses thereof
|
CZ2001149A3
(cs)
|
1998-07-14 |
2002-02-13 |
Corixa Corporation |
Prostředky a způsoby pro terapii a diagnostiku karcinomu prostaty
|
JP2002532083A
(ja)
|
1998-12-17 |
2002-10-02 |
ヒューマン ジノーム サイエンシーズ, インコーポレイテッド |
47個のヒト分泌タンパク質
|
US6737056B1
(en)
|
1999-01-15 |
2004-05-18 |
Genentech, Inc. |
Polypeptide variants with altered effector function
|
JP4926320B2
(ja)
|
1999-04-28 |
2012-05-09 |
ボード・オブ・リージエンツ,ザ・ユニバーシテイ・オブ・テキサス・システム |
Vegfの選択的阻害による癌処置のための組成物および方法
|
CA2387696A1
(en)
|
1999-06-11 |
2000-12-21 |
Human Genome Sciences, Inc. |
48 human secreted proteins
|
JP2003527089A
(ja)
|
1999-08-17 |
2003-09-16 |
インサイト・ゲノミックス・インコーポレイテッド |
膜関連タンパク質
|
US7125978B1
(en)
|
1999-10-04 |
2006-10-24 |
Medicago Inc. |
Promoter for regulating expression of foreign genes
|
ATE303445T1
(de)
|
1999-10-04 |
2005-09-15 |
Medicago Inc |
Verfahren zur regulation der transkription von fremden genen in gegenwart von stickstoff
|
AU7994200A
(en)
|
1999-10-04 |
2001-05-10 |
Corixa Corporation |
Compositions and methods for therapy and diagnosis of prostate cancer
|
UA74798C2
(uk)
|
1999-10-06 |
2006-02-15 |
Байоджен Айдек Ма Інк. |
Спосіб лікування раку у ссавця за допомогою поліпептиду, що протидіє взаємодії april з його рецепторами
|
JP2004537252A
(ja)
|
1999-11-12 |
2004-12-16 |
コリクサ コーポレイション |
前立腺癌の治療及び診断のための組成物及び方法
|
AU775366B2
(en)
|
1999-12-06 |
2004-07-29 |
Agensys, Inc. |
Serpentine transmembrane antigens expressed in human cancers and uses thereof
|
JP2003516755A
(ja)
|
1999-12-15 |
2003-05-20 |
ジェネンテック・インコーポレーテッド |
ショットガン走査、すなわち機能性タンパク質エピトープをマッピングするための組み合わせ方法
|
CN1436234A
(zh)
|
2000-01-14 |
2003-08-13 |
科里克萨有限公司 |
用于前列腺癌治疗和诊断的组合物及方法
|
AU2001234944A1
(en)
|
2000-02-03 |
2001-08-14 |
Hyseq, Inc. |
Novel nucleic acids and polypeptides
|
AU2001236589A1
(en)
|
2000-02-04 |
2001-08-14 |
Aeomica, Inc. |
Methods and apparatus for high-throughput detection and characterization of alternatively spliced genes
|
AU2001241541A1
(en)
|
2000-02-17 |
2001-08-27 |
Millennium Predictive Medicine, Inc. |
Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of human prostate cancer
|
AU2001249411B2
(en)
|
2000-03-24 |
2007-02-15 |
Fahri Saatcioglu |
Novel prostate-specific or testis-specific nucleic acid molecules, polypeptides,and diagnostic and therapeutic methods
|
WO2001073032A2
(en)
|
2000-03-27 |
2001-10-04 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
US6436703B1
(en)
|
2000-03-31 |
2002-08-20 |
Hyseq, Inc. |
Nucleic acids and polypeptides
|
CN101289511A
(zh)
|
2000-04-11 |
2008-10-22 |
杰南技术公司 |
多价抗体及其应用
|
EP1358349A2
(en)
|
2000-06-05 |
2003-11-05 |
Avalon Pharmaceuticals |
Cancer gene determination and therapeutic screening using signature gene sets
|
WO2001096388A2
(en)
|
2000-06-09 |
2001-12-20 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of colon cancer
|
WO2002010449A2
(en)
|
2000-07-28 |
2002-02-07 |
Compugen Inc. |
Oligonucleotide library for detecting rna transcripts and splice variants that populate a transcriptome
|
KR20030029847A
(ko)
|
2000-08-24 |
2003-04-16 |
제넨테크, 인크. |
종양의 진단 및 치료를 위한 조성물 및 방법
|
CA2425569A1
(en)
|
2000-10-13 |
2002-04-18 |
Eos Biotechnology, Inc. |
Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer
|
US6596541B2
(en)
|
2000-10-31 |
2003-07-22 |
Regeneron Pharmaceuticals, Inc. |
Methods of modifying eukaryotic cells
|
EP1341804A4
(en)
|
2000-11-17 |
2005-08-24 |
Nuvelo Inc |
NEW NUCLEIC ACIDS AND POLYPEPTIDES
|
AU3942202A
(en)
|
2000-11-30 |
2002-06-11 |
Medarex Inc |
Transgenic transchromosomal rodents for making human antibodies
|
US20030055220A1
(en)
|
2001-01-12 |
2003-03-20 |
Pierre Legrain |
Protein-protein interactions between Shigella flexneri polypeptides and mammalian polypeptides
|
EP1414845A4
(en)
|
2001-03-21 |
2009-07-08 |
Human Genome Sciences |
SEPARATE HUMAN PROTEINS
|
WO2003009814A2
(en)
|
2001-07-25 |
2003-02-06 |
Millennium Pharmaceuticals, Inc. |
Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer
|
AU2002339845B2
(en)
|
2001-08-03 |
2009-03-26 |
Roche Glycart Ag |
Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
|
US7494646B2
(en)
|
2001-09-06 |
2009-02-24 |
Agensys, Inc. |
Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
|
JP2005505271A
(ja)
|
2001-09-06 |
2005-02-24 |
アジェンシス, インコーポレイテッド |
癌の処置および検出において有用なsteap−1と名称が与えられる核酸および対応するタンパク質
|
WO2003022955A1
(en)
|
2001-09-11 |
2003-03-20 |
Nessdisplay Co., Ltd. |
Organic electroluminescent device having a polyimide hole transport layer
|
US7091186B2
(en)
|
2001-09-24 |
2006-08-15 |
Seattle Genetics, Inc. |
p-Amidobenzylethers in drug delivery agents
|
MXPA04003798A
(es)
|
2001-10-25 |
2004-07-30 |
Genentech Inc |
Composiciones de glicoproteina.
|
EP1308459A3
(en)
|
2001-11-05 |
2003-07-09 |
Research Association for Biotechnology |
Full-length cDNA sequences
|
US20040093621A1
(en)
|
2001-12-25 |
2004-05-13 |
Kyowa Hakko Kogyo Co., Ltd |
Antibody composition which specifically binds to CD20
|
ATE503829T1
(de)
|
2002-04-09 |
2011-04-15 |
Kyowa Hakko Kirin Co Ltd |
Zelle mit erniedrigter oder deletierter aktivität eines am gdp-fucosetransport beteiligten proteins
|
EA200401325A1
(ru)
|
2002-04-09 |
2005-04-28 |
Киова Хакко Когио Ко., Лтд. |
Клетки с модифицированным геномом
|
AU2003236019A1
(en)
|
2002-04-09 |
2003-10-20 |
Kyowa Hakko Kirin Co., Ltd. |
Drug containing antibody composition appropriate for patient suffering from Fc Gamma RIIIa polymorphism
|
WO2003085118A1
(fr)
|
2002-04-09 |
2003-10-16 |
Kyowa Hakko Kogyo Co., Ltd. |
Procede de production de composition anticorps
|
CA2481658A1
(en)
|
2002-04-09 |
2003-10-16 |
Kyowa Hakko Kogyo Co., Ltd. |
Method of enhancing of binding activity of antibody composition to fcy receptor iiia
|
AU2003239966B9
(en)
|
2002-06-03 |
2010-08-26 |
Genentech, Inc. |
Synthetic antibody phage libraries
|
DK1545613T3
(da)
|
2002-07-31 |
2011-11-14 |
Seattle Genetics Inc |
Auristatinkonjugater og deres anvendelse til behandling af cancer, en autoimmun sygdom eller en infektiøs sygdom
|
SI1572744T1
(sl)
|
2002-12-16 |
2010-09-30 |
Genentech Inc |
Imunoglobulinske variante in njihove uporabe
|
CA2510003A1
(en)
|
2003-01-16 |
2004-08-05 |
Genentech, Inc. |
Synthetic antibody phage libraries
|
KR101498588B1
(ko)
|
2003-01-22 |
2015-03-05 |
로슈 글리카트 아게 |
융합 구성체와 Fc 수용체 결합 친화도 및 이펙터 기능이 증가된 항체를 생성하기 위한 이의 용도
|
JP4593557B2
(ja)
|
2003-02-27 |
2010-12-08 |
ベリデックス・リミテッド・ライアビリティ・カンパニー |
循環腫瘍細胞(ctc):転移癌患者における増悪までの時間、生存および療法に対する応答の早期評価
|
WO2004106381A1
(en)
|
2003-05-31 |
2004-12-09 |
Micromet Ag |
Pharmaceutical compositions comprising bispecific anti-cd3, anti-cd19 antibody constructs for the treatment of b-cell related disorders
|
DK1725249T3
(en)
|
2003-11-06 |
2014-03-17 |
Seattle Genetics Inc |
Monomethylvaline compounds capable of conjugating to ligands.
|
US7235641B2
(en)
|
2003-12-22 |
2007-06-26 |
Micromet Ag |
Bispecific antibodies
|
JP5128935B2
(ja)
|
2004-03-31 |
2013-01-23 |
ジェネンテック, インコーポレイテッド |
ヒト化抗TGF−β抗体
|
US7785903B2
(en)
|
2004-04-09 |
2010-08-31 |
Genentech, Inc. |
Variable domain library and uses
|
DK1737891T3
(da)
|
2004-04-13 |
2013-03-25 |
Hoffmann La Roche |
Anti-p-selectin-antistoffer
|
WO2005113601A2
(en)
*
|
2004-04-22 |
2005-12-01 |
Agensys, Inc. |
Antibodies and molecules derived therefrom that bind to steap-1 proteins
|
TWI380996B
(zh)
|
2004-09-17 |
2013-01-01 |
Hoffmann La Roche |
抗ox40l抗體
|
KR101270829B1
(ko)
|
2004-09-23 |
2013-06-07 |
제넨테크, 인크. |
시스테인 유전자조작 항체 및 접합체
|
CN103981190A
(zh)
|
2005-02-07 |
2014-08-13 |
罗氏格黎卡特股份公司 |
结合egfr的抗原结合分子,编码它的载体,及其应用
|
JP5620626B2
(ja)
|
2005-03-31 |
2014-11-05 |
中外製薬株式会社 |
会合制御によるポリペプチド製造方法
|
US7612181B2
(en)
|
2005-08-19 |
2009-11-03 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
EP3770174A1
(en)
|
2005-10-11 |
2021-01-27 |
Amgen Research (Munich) GmbH |
Compositions comprising cross-species-specific antibodies and uses thereof
|
WO2007056441A2
(en)
|
2005-11-07 |
2007-05-18 |
Genentech, Inc. |
Binding polypeptides with diversified and consensus vh/vl hypervariable sequences
|
EP1973951A2
(en)
|
2005-12-02 |
2008-10-01 |
Genentech, Inc. |
Binding polypeptides with restricted diversity sequences
|
AR060070A1
(es)
|
2006-03-24 |
2008-05-21 |
Merck Patent Gmbh |
Dominios proteicos heterodimericos obtenidos por ingenieria
|
JP2009536527A
(ja)
|
2006-05-09 |
2009-10-15 |
ジェネンテック・インコーポレーテッド |
最適化されたスキャフォールドを備えた結合ポリペプチド
|
WO2007147901A1
(en)
|
2006-06-22 |
2007-12-27 |
Novo Nordisk A/S |
Production of bispecific antibodies
|
US20080044455A1
(en)
|
2006-08-21 |
2008-02-21 |
Chaim Welczer |
Tonsillitus Treatment
|
PL2059533T3
(pl)
|
2006-08-30 |
2013-04-30 |
Genentech Inc |
Przeciwciała wieloswoiste
|
WO2011008990A1
(en)
|
2009-07-15 |
2011-01-20 |
Prometheus Laboratories Inc. |
Drug selection for gastric cancer therapy using antibody-based arrays
|
CN101573384B
(zh)
|
2006-10-27 |
2013-02-20 |
健泰科生物技术公司 |
抗体和免疫偶联物及其用途
|
CA2667019C
(en)
|
2006-10-27 |
2016-03-29 |
Genentech, Inc. |
Antibodies and immunoconjugates and uses therefor
|
SI2155783T1
(sl)
|
2007-04-03 |
2013-10-30 |
Amgen Research (Munich) Gmbh |
Medvrstno specifiäśna cd3-epsilon vezavna domena
|
US20090162359A1
(en)
|
2007-12-21 |
2009-06-25 |
Christian Klein |
Bivalent, bispecific antibodies
|
US8242247B2
(en)
|
2007-12-21 |
2012-08-14 |
Hoffmann-La Roche Inc. |
Bivalent, bispecific antibodies
|
US9266967B2
(en)
|
2007-12-21 |
2016-02-23 |
Hoffmann-La Roche, Inc. |
Bivalent, bispecific antibodies
|
KR20100137416A
(ko)
|
2007-12-27 |
2010-12-30 |
인피니티 파마슈티칼스, 인코포레이티드 |
암 치료법
|
PL2235064T3
(pl)
|
2008-01-07 |
2016-06-30 |
Amgen Inc |
Sposób otrzymywania cząsteczek przeciwciał z heterodimerycznymi fc z zastosowaniem kierujących efektów elektrostatycznych
|
US20100291584A1
(en)
|
2008-02-01 |
2010-11-18 |
The Regents Of The University Of California |
Microfluidic imaging cytometry
|
IT1391619B1
(it)
|
2008-11-04 |
2012-01-11 |
Silicon Biosystems Spa |
Metodo per l'individuazione, selezione e analisi di cellule tumorali
|
CN107184976A
(zh)
|
2008-11-20 |
2017-09-22 |
弗·哈夫曼-拉罗切有限公司 |
治疗性蛋白质制剂
|
WO2010112193A1
(en)
|
2009-04-02 |
2010-10-07 |
Roche Glycart Ag |
Multispecific antibodies comprising full length antibodies and single chain fab fragments
|
PT2417156E
(pt)
|
2009-04-07 |
2015-04-29 |
Roche Glycart Ag |
Anticorpos trivalentes, biespecíficos
|
ES2708124T3
(es)
|
2009-04-27 |
2019-04-08 |
Oncomed Pharm Inc |
Procedimiento para preparar moléculas heteromultiméricas
|
AU2010252284A1
(en)
|
2009-05-27 |
2011-11-17 |
F. Hoffmann-La Roche Ag |
Tri- or tetraspecific antibodies
|
US9676845B2
(en)
|
2009-06-16 |
2017-06-13 |
Hoffmann-La Roche, Inc. |
Bispecific antigen binding proteins
|
SG179196A1
(en)
|
2009-09-16 |
2012-04-27 |
Genentech Inc |
Coiled coil and/or tether containing protein complexes and uses thereof
|
US9034658B2
(en)
|
2009-11-23 |
2015-05-19 |
The General Hospital Corporation |
Microfluidic devices for the capture of biological sample components
|
DK2519543T3
(en)
|
2009-12-29 |
2016-09-26 |
Emergent Product Dev Seattle |
HETERODIMER BINDING PROTEINS AND USE THEREOF
|
WO2011115892A1
(en)
|
2010-03-15 |
2011-09-22 |
Griffin Patrick R |
Modulators of the retinoic acid receptor-related orphan receptors
|
US9469876B2
(en)
|
2010-04-06 |
2016-10-18 |
Caris Life Sciences Switzerland Holdings Gmbh |
Circulating biomarkers for metastatic prostate cancer
|
US9527926B2
(en)
|
2010-05-14 |
2016-12-27 |
Rinat Neuroscience Corp. |
Heterodimeric proteins and methods for producing and purifying them
|
NZ602840A
(en)
|
2010-06-03 |
2014-11-28 |
Genentech Inc |
Immuno-pet imaging of antibodies and immunoconjugates and uses therefor
|
WO2011156328A1
(en)
|
2010-06-08 |
2011-12-15 |
Genentech, Inc. |
Cysteine engineered antibodies and conjugates
|
CN101943703A
(zh)
|
2010-06-28 |
2011-01-12 |
首都医科大学 |
一种基于纳米技术的微量蛋白质检测方法
|
EP2635607B1
(en)
|
2010-11-05 |
2019-09-04 |
Zymeworks Inc. |
Stable heterodimeric antibody design with mutations in the fc domain
|
ES2692268T3
(es)
|
2011-03-29 |
2018-12-03 |
Roche Glycart Ag |
Variantes de Fc de anticuerpo
|
CN103619881B
(zh)
|
2011-04-07 |
2017-07-28 |
安姆根有限公司 |
新的egfr结合蛋白
|
JP6159724B2
(ja)
|
2011-08-23 |
2017-07-05 |
ロシュ グリクアート アーゲー |
T細胞活性化抗原に対して特異的な二重特異性抗体及び腫瘍抗原および使用方法
|
ES2857734T3
(es)
|
2011-08-23 |
2021-09-29 |
Roche Glycart Ag |
Moléculas de unión a antígeno activadoras de linfocitos T biespecíficas
|
EP2748202B1
(en)
|
2011-08-23 |
2018-07-04 |
Roche Glycart AG |
Bispecific antigen binding molecules
|
CA2854042A1
(en)
|
2011-11-29 |
2013-06-06 |
Genentech, Inc. |
Compositions and methods for prostate cancer analysis
|
CN102492772A
(zh)
|
2011-12-02 |
2012-06-13 |
中国人民解放军军事医学科学院放射与辐射医学研究所 |
一种分子检测信号放大技术
|
WO2013086031A1
(en)
|
2011-12-05 |
2013-06-13 |
Nestec S.A. |
Method of therapy selection for patients with cancer
|
CA2859667C
(en)
|
2011-12-20 |
2022-05-24 |
Medimmune, Llc |
Modified polypeptides for bispecific antibody scaffolds
|
WO2013111054A1
(en)
|
2012-01-24 |
2013-08-01 |
Pfizer Inc. |
Methods for detecting 5t4-positive circulating tumor cells and methods of diagnosis of 5t4-positive cancer in a mammalian subject
|
WO2013120929A1
(en)
|
2012-02-15 |
2013-08-22 |
F. Hoffmann-La Roche Ag |
Fc-receptor based affinity chromatography
|
CN114163530A
(zh)
|
2012-04-20 |
2022-03-11 |
美勒斯公司 |
用于产生免疫球蛋白样分子的方法和手段
|
CN103792364B
(zh)
|
2012-10-31 |
2016-06-08 |
张宝弘 |
用于检测外周血中循环肿瘤细胞ror1蛋白的试剂及其应用
|
WO2014165818A2
(en)
|
2013-04-05 |
2014-10-09 |
T Cell Therapeutics, Inc. |
Compositions and methods for preventing and treating prostate cancer
|
ES2651522T3
(es)
|
2013-12-16 |
2018-01-26 |
Humanitas Mirasole S.P.A. |
Altos niveles de FT de TEM para el diagnóstico del cáncer, en particular de cáncer colorrectal (CCR) y de páncreas (CP)
|
JP7325166B2
(ja)
|
2013-12-20 |
2023-08-14 |
ジェネンテック, インコーポレイテッド |
二重特異性抗体
|
AU2015209154A1
(en)
|
2014-01-24 |
2017-02-16 |
Genentech, Inc. |
Methods of using anti-STEAP1 antibodies and immunoconjugates
|
AP2016009475A0
(en)
*
|
2014-03-28 |
2016-09-30 |
Xencor Inc |
Bispecific antibodies that bind to cd38 and cd3
|
UA117289C2
(uk)
|
2014-04-02 |
2018-07-10 |
Ф. Хоффманн-Ля Рош Аг |
Мультиспецифічне антитіло
|
ES2755406T3
(es)
|
2014-04-17 |
2020-04-22 |
Siemens Healthcare Diagnostics Inc |
Método para evitar positivos falsos en un ensayo de células tumorales circulantes
|
CN106573986A
(zh)
|
2014-07-29 |
2017-04-19 |
豪夫迈·罗氏有限公司 |
多特异性抗体
|
CA2951599A1
(en)
|
2014-08-04 |
2016-02-11 |
F. Hoffmann-La Roche Ag |
Bispecific t cell activating antigen binding molecules
|
CN107108724A
(zh)
|
2014-09-12 |
2017-08-29 |
豪夫迈·罗氏有限公司 |
半胱氨酸改造抗体和缀合物
|
CA2980189A1
(en)
|
2015-04-24 |
2016-10-27 |
Genentech, Inc. |
Multispecific antigen-binding proteins
|
WO2016205176A1
(en)
*
|
2015-06-15 |
2016-12-22 |
Genentech, Inc. |
Antibodies and immunoconjugates
|